Pfizer stock (PFE) edges up ahead of Feb. 3 earnings as obesity pricing shifts and RSV dispute draw focus
Pfizer Inc shares edged up roughly 0.3% to $26.51 by mid-afternoon Monday, ahead of its quarterly earnings report set for Feb. 3. The stock fluctuated between $26.34 and $26.58, with volume hitting around 34.4 million shares.
